The technetium-99m market is expected to reach US$6.29 billion by 2031 from US$ 4.61 billion in 2024; it is anticipated to register a CAGR of 3.9% during the forecast period. Technetium-99m (Tc-99m) ...

Wilmington, Delaware, Transparency Market Research, Inc., Nov. 28, 2024 (GLOBE NEWSWIRE) -- The Technetium-99m market (Marché du technétium-99m) is experiencing significant growth due to its essential ...

Scientists in Canada are the first to make commercial quantities of the medical isotope technetium-99m using medical cyclotrons. The material is currently made in just a few ageing nuclear reactors ...

Bayer is acquiring two investigational molecular imaging agents from Attralus for the diagnosis of cardiac amyloidosis.

BURNABY, British Columbia--(BUSINESS WIRE)--ARTMS Inc. (ARTMS) is excited to announce Health Canada’s marketing approval of cyclotron produced technetium-99m (99m Tc) for clinical use. For the Health ...

MRI scan The FDA announced that it has approved a new technology known as the RadioGenix System to produce the country's own supply of the radioisotope Technetium-99m (Tc-99m). (HealthDay News) — A ...

The medical isotope technetium-99m (Tc-99m) could be made in hospitals rather than nuclear reactors. That is the conclusion of researchers in Canada, who have done theoretical modelling of how the ...

− Collaboration enables integrating technology expertise to provide Tc-99m Generation Systems (TCM Generation Systems) that utilize non-uranium based Mo-99 produced using electron beam accelerators − ...

NEW YORK, July 18, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global technetium-99m market is witnessing substantial growth with the surging prevalence ...